Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
GUJINJECLTD Gujarat Inject (Kerala) Ltd	Healthcare	5	n/a	up+2,363.6%	0	n/a	0.00	No estimate
ISHITADRUGSINDUSLTD Ishita Drugs & Industries Ltd	Healthcare	5	n/a	up+40.2%	0	n/a	0.94	No estimate
UNJHAFORMULATIONSLTD	Healthcare	4	n/a	down−20.2%	0	n/a	−0.40	No estimate
VIVANZABIOSCIENCESLTD	Healthcare	4	n/a	down−32.6%	0	n/a	−0.10	No estimate
PARMAXPHARMALTD	Healthcare	4	n/a	up+220.3%	−1	n/a	−3.88	No estimate
SHREEGANESHBIOTECHINDIALTD	Healthcare	4	n/a	down−8.3%	1	n/a	0.01	No estimate
VANTABIOSCIENCELTD	Healthcare	4	up+2.9%	n/a	−2	n/a	−2.82	No estimate
BRAWNPHARMACEUTICALSLTD Brawn Biotech Ltd	Healthcare	3	n/a	up+21.5%	0	n/a	−1.13	No estimate
VEERHEALTHCARELTD	Healthcare	3	n/a	up+17.4%	−1	n/a	−0.28	No estimate
BERYLDRUGSLTD	Healthcare	3	n/a	down−58.1%	0	n/a	−0.69	No estimate
VISTAPHARMACEUTICALSLTD	Healthcare	3	n/a	up+84.1%	0	n/a	0.02	No estimate
ZENITHHEALTHCARELTD	Healthcare	3	n/a	down−21.1%	0	n/a	−0.05	No estimate
Span Divergent Ltd	Healthcare	3	n/a	up+0.7%	1	n/a	1.68	No estimate
Sangam Health Care Products Ltd	Healthcare	3	n/a	down−15.9%	0	n/a	−0.09	No estimate
MEDINOVADIAGNOSTICSERVICELTD Medinova Diagnostic Services Ltd	Healthcare	2	down−9.5%	up+4.2%	1	down−22.1%	0.60	No estimate
DESHRAKSHAKAUSHDHALAYALTD	Healthcare	2	n/a	up+57.6%	0	n/a	0.36	No estimate
Medinova Diagnostic Services Ltd	Healthcare	2	down−9.5%	up+4.2%	1	down−22.1%	0.60	No estimate
SUVEN Suven Life Sciences Ltd	Healthcare	2	n/a	0.0%	−27	n/a	−1.22	No estimate
MEDICAPQ Medi Caps Ltd	Healthcare	2	n/a	down−35.4%	1	n/a	0.52	No estimate
COLINZLABORATORIESLTD	Healthcare	2	n/a	down−4.7%	0	n/a	0.56	No estimate
GANGAPHARMACEUTICALSLTD	Healthcare	1	up+15.4%	n/a	0	up+200.0%	0.06	No estimate
AMBALALSA Ambalal Sarabhai Enterprises Ltd	Healthcare	1	n/a	up+200.0%	5	n/a	0.61	No estimate
MURAEORGANISORLTD	Healthcare	1	down−43.8%	up+115.0%	1	up+350.0%	0.02	No estimate
RUBRAMEDICAMENTSLTD Centuple Global Ltd	Healthcare	0	n/a	up+176.5%	0	n/a	−0.42	No estimate
TRANSCHEMLTD	Healthcare	0	n/a	n/a	1	n/a	1.02	No estimate
Transchem Ltd	Healthcare	0	n/a	n/a	1	n/a	1.02	No estimate
ORTINGLOBE Ortin Global Ltd	Healthcare	0	n/a	up+114.3%	−4	n/a	−5.09	No estimate
SHYAMAINFOLTD Shyama Computronics and Services Ltd	Healthcare	0	n/a	up+20.0%	0	n/a	0.08	No estimate
CHEMOPHARMALABORATORIESLTD Starsource Multitrade Ltd	Healthcare	0	n/a	n/a	0	n/a	−1.93	No estimate
TRIOCHEMPRODUCTSLTD	Healthcare	0	n/a	n/a	0	n/a	13.06	No estimate
GENESISIBRCINDIALTD CCME Global Ltd	Healthcare	0	n/a	n/a	−4	n/a	−2.84	No estimate
KABRADRUGSLTD	Healthcare	0	n/a	n/a	0	n/a	−0.84	No estimate
BACILPHARMALTD	Healthcare	0	n/a	n/a	0	n/a	−0.07	No estimate
KAMRONLABORATORIESLTD Adline Chem Lab Ltd	Healthcare	0	n/a	n/a	0	n/a	−0.07	No estimate
WELCUREDRUGSPHARMACEUTICALSLTD Welcure Drugs & Pharmaceuticals Ltd	Healthcare	0	n/a	n/a	0	n/a	0.00	No estimate
REKVINALABORATORIESLTD Rekvina Labs Ltd	Healthcare	0	n/a	n/a	0	n/a	0.00	No estimate
VENMAXDRUGSPHARMACEUTICALSLTD Venmax Drugs & Pharmaceuticals Ltd	Healthcare	0	n/a	n/a	0	n/a	0.10	No estimate
RAYMEDLABSLTD Cresanto Global Limited	Healthcare	0	n/a	n/a	0	n/a	−0.12	No estimate
MPS Pharmaa Ltd	Healthcare	0	n/a	n/a	0	n/a	−0.13	No estimate
GENOMICVALLEYBIOTECHLTD	Healthcare	0	n/a	down−100.0%	0	n/a	−0.13	No estimate
TRANSPACTENTERPRISESLTD	Healthcare	0	n/a	n/a	0	n/a	−1.55	No estimate
TAKE Take Ltd	Healthcare	0	n/a	n/a	−111	n/a	−7.48	No estimate
Harleystreet Pharmaceuticals Ltd(merged)	Healthcare	—	n/a	n/a	156	up+9.9%	4.98	No estimate

About Q4 FY24 earnings data

When are Q4 FY24 results announced?

Q4 FY24 covers the Jan–Mar 2024 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

Why do some Q4 FY24 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No analyst consensus was available for Q4 FY24, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q4 FY24?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.